Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

Liver Transplantation

Volumn 7, Issue 3, 2001, Pages 255-263

  Jonsson, Julie R ^a,b,c,d   Hong, Cui ^a,b,c,d   Purdie, David M ^a,b,c,d   Hawley, Carmel ^a,b,c,d   Isbel, Nicky ^a,b,c,d   Butler, Maree ^a,b,c,d   Balderson, Glenda A ^a,b,c,d   Clouston, Andrew D ^a,b,c,d   Pandeya, Nirmala ^a,b,c,d   Stuart, Katherine ^a,b,c,d   Edwards Smith, Catherine ^a,b,c,d   Crawford, Darrell H ^a,b,c,d   Fawcett, Jonathon ^a,b,c,d   Powell, Elizabeth E ^a,b,c,d  

^a Department of Surgery ^*  (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALKALINE PHOSPHATASE; AZATHIOPRINE; BILIRUBIN; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; CYTOKINE; CYTOSINE; DNA; GAMMA GLUTAMYLTRANSFERASE; GUANINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; METHYLPREDNISOLONE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; GRAFT REJECTION; HLA MATCHING; HUMAN; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DISEASE; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS HEPATITIS;

EID: 17744365363     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.22450     Document Type: Article

References (35)

1. What is the significance of acute liver allograft rejection?
2. Medical problems occurring after orthotopic liver transplantation
3. Chronic renal failure following liver transplantation: A retrospective analysis
4. Cytokines in transplantation
5. An investigation of polymorphism in the interleukin-10 gene promoter
6. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
7. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation
8. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation
9. Cytokine gene polymorphism and heart transplant rejection
10. Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: Demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine
11. Tacrolimus induces increased expression of transforming growth factor-beta 1 in mammalian lymphoid as well as nonlymphoid cells
12. TGF-beta gene polymorphism does not influence the rise in creatinine following cardiac transplantation
13. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation
14. Donor polymorphism of tumor necrosis factor gene: Relationship with variable severity of hepatitis C recurrence after liver transplantation
15. Prediction of creatinine clearance from serum creatinine
16. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
17. Rapid genotyping of transforming growth factor beta1 gene polymorphisms in a UK Caucasoid control population using the polymerase chain reaction and sequence-specific primers
18. Host genetic factors influence disease progression in chronic hepatitis C
19. Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: A technical report
20. The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis
21. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis
22. Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis
23. The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation
24. T cells and B cells in chronic renal failure
25. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation
26. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
27. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "The dualistic effect"
28. A large, single center investigation of the immunogenetic factors affecting liver transplantation
29. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection
30. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis
31. TNF gene polymorphisms in primary biliary cirrhosis: A critical appraisal
32. Expression of cytokines and factors modulating apoptosis by human sinusoidal leucocytes
33. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection
34. Renal disease in hepatitis C-positive liver transplant recipients